• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际植物科学界在抗击人类传染病方面的贡献 - 第 1 部分:传染病和大流行疾病。

Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.

机构信息

Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain.

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.

出版信息

Plant Biotechnol J. 2021 Oct;19(10):1901-1920. doi: 10.1111/pbi.13657. Epub 2021 Jul 19.

DOI:
10.1111/pbi.13657
PMID:34182608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8486245/
Abstract

Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ˜17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world.

摘要

传染病,又称传染性或传染性疾病,是由病原体或寄生虫引起的,通过直接接触感染者或受污染的材料、飞沫和气溶胶,或通过昆虫等媒介在社区中传播。这些疾病导致全球所有人类死亡的 17%左右,其管理和控制给全球医疗系统带来了巨大负担。传染病的传统预防和控制方法包括疫苗接种计划、卫生措施和抑制病原体的药物、治疗疾病症状或减轻宿主免疫系统的剧烈反应的药物。疫苗和生物药物(如抗体)的提供受到基于微生物和动物细胞的传统制造平台的高成本和有限可扩展性的限制,特别是在传染病流行且控制不力的发展中国家。利用植物进行蛋白质表达的分子农业是解决当前制造平台缺陷的一种有前途的策略。在这篇综述文章中,我们考虑了分子农业在满足最普遍和最重要的传染病和大流行疾病的医疗需求方面的潜力,重点关注高死亡率冠状病毒感染和不成比例地影响发展中国家的疾病的最新爆发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f5e/11389860/62ac2f4dad62/PBI-19-1901-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f5e/11389860/ebde600d3538/PBI-19-1901-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f5e/11389860/b6e5ffcf4ae3/PBI-19-1901-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f5e/11389860/62ac2f4dad62/PBI-19-1901-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f5e/11389860/ebde600d3538/PBI-19-1901-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f5e/11389860/b6e5ffcf4ae3/PBI-19-1901-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f5e/11389860/62ac2f4dad62/PBI-19-1901-g003.jpg

相似文献

1
Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.国际植物科学界在抗击人类传染病方面的贡献 - 第 1 部分:传染病和大流行疾病。
Plant Biotechnol J. 2021 Oct;19(10):1901-1920. doi: 10.1111/pbi.13657. Epub 2021 Jul 19.
2
Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.国际植物科学界为人类防治传染病做出的贡献 2:可食用植物中的廉价药物用于防治地方性和再现传染病。
Plant Biotechnol J. 2021 Oct;19(10):1921-1936. doi: 10.1111/pbi.13658. Epub 2021 Jul 19.
3
Tuberculosis结核病
4
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
5
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
6
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.飞沫和气溶胶传播 SARS-CoV-2 的传染性和脱落的异质性。
Elife. 2021 Apr 16;10:e65774. doi: 10.7554/eLife.65774.
7
OSHA Bloodborne Pathogen Standards职业安全与健康管理局血源性病原体标准
8
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?解除新冠肺炎大流行后的非药物干预措施——暴风雨前的宁静?
Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5.
9
Within-host diversity improves phylogenetic and transmission reconstruction of SARS-CoV-2 outbreaks.宿主内多样性提高了 SARS-CoV-2 爆发的系统发育和传播重建。
Elife. 2023 Sep 21;12:e84384. doi: 10.7554/eLife.84384.
10
Changing patterns of infectious diseases in children during the COVID-19 pandemic.儿童传染病模式在 COVID-19 大流行期间的变化。
Front Cell Infect Microbiol. 2023 Jun 29;13:1200617. doi: 10.3389/fcimb.2023.1200617. eCollection 2023.

引用本文的文献

1
Rhinovirus, an Age-Old Problem Yet to be Solved: A Comprehensive Review Discussing Modern Therapeutics.鼻病毒,一个尚未解决的古老问题:一篇讨论现代疗法的综述
Health Sci Rep. 2025 Aug 6;8(8):e70922. doi: 10.1002/hsr2.70922. eCollection 2025 Aug.
2
Industrial applications of Phanerochaete chrysosporium lignin-degrading enzymes: current status, production challenges, and future directions.黄孢原毛平革菌木质素降解酶的工业应用:现状、生产挑战及未来方向
World J Microbiol Biotechnol. 2025 May 9;41(5):171. doi: 10.1007/s11274-025-04388-6.
3
Plant-made pharmaceuticals.

本文引用的文献

1
Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.国际植物科学界为人类防治传染病做出的贡献 2:可食用植物中的廉价药物用于防治地方性和再现传染病。
Plant Biotechnol J. 2021 Oct;19(10):1921-1936. doi: 10.1111/pbi.13658. Epub 2021 Jul 19.
2
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19.一种用于新冠肺炎的植物源病毒样颗粒疫苗的1期随机试验。
Nat Med. 2021 Jun;27(6):1071-1078. doi: 10.1038/s41591-021-01370-1. Epub 2021 May 18.
3
SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients.
植物源药物。
Plant Biotechnol (Tokyo). 2024 Sep 25;41(3):243-260. doi: 10.5511/plantbiotechnology.24.0716a.
4
Impact of Gene Knockout on Cell Aggregation in Suspension Culture.基因敲除对悬浮培养中细胞聚集的影响。
BioTech (Basel). 2025 Jan 2;14(1):2. doi: 10.3390/biotech14010002.
5
Anti-Inflammatory Effects of Helminth-Derived Products: Potential Applications and Challenges in Diabetes Mellitus Management.蠕虫衍生产品的抗炎作用:在糖尿病管理中的潜在应用与挑战
J Inflamm Res. 2024 Dec 28;17:11789-11812. doi: 10.2147/JIR.S493374. eCollection 2024.
6
A time series study of the association between extreme temperature and ozone on varicella incidence.一项关于极端温度与臭氧对水痘发病率影响的关联的时间序列研究。
Sci Rep. 2024 Dec 28;14(1):31187. doi: 10.1038/s41598-024-82306-w.
7
Biotechnological Interventions for the Production of Subunit Vaccines Against Group A Rotavirus.用于生产抗A组轮状病毒亚单位疫苗的生物技术干预措施。
Cell Biochem Funct. 2024 Dec;42(8):e70031. doi: 10.1002/cbf.70031.
8
Production of Plant Virus-Derived Hybrid Nanoparticles Decorated with Different Nanobodies.生产用不同纳米抗体修饰的植物病毒衍生杂交纳米颗粒。
ACS Nano. 2024 Dec 17;18(50):33890-33906. doi: 10.1021/acsnano.4c07066. Epub 2024 Dec 2.
9
Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems.探索植物系统中用于治疗性和重组分子的分子农业的最新进展。
Heliyon. 2024 Sep 7;10(18):e37634. doi: 10.1016/j.heliyon.2024.e37634. eCollection 2024 Sep 30.
10
Harnessing controlled-environment systems for enhanced production of medicinal plants.利用可控环境系统提高药用植物产量。
J Exp Bot. 2025 Jan 1;76(1):76-93. doi: 10.1093/jxb/erae248.
植物中表达的SARS-CoV-2抗原可检测COVID-19患者的抗体反应。
Front Plant Sci. 2021 Mar 31;12:589940. doi: 10.3389/fpls.2021.589940. eCollection 2021.
4
The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses.SARS-CoV-2 S 蛋白糖基化在 SARS-CoV-2/ACE2 相互作用和免疫反应中的作用。
Viral Immunol. 2021 Apr;34(3):165-173. doi: 10.1089/vim.2020.0174. Epub 2021 Feb 19.
5
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age.III 期:在 18-49 岁成人中评估一种新的植物源性四价病毒样颗粒流感疫苗批间一致性的随机观察者盲法试验。
Vaccine. 2021 Mar 5;39(10):1528-1533. doi: 10.1016/j.vaccine.2021.01.004. Epub 2021 Feb 10.
6
Green giant-a tiny chloroplast genome with mighty power to produce high-value proteins: history and phylogeny.绿巨人——一个拥有生产高价值蛋白强大能力的微小叶绿体基因组:历史与系统发育。
Plant Biotechnol J. 2021 Mar;19(3):430-447. doi: 10.1111/pbi.13556. Epub 2021 Feb 22.
7
REGN-EB3: First Approval.REGN-EB3:首次批准。
Drugs. 2021 Jan;81(1):175-178. doi: 10.1007/s40265-020-01452-3.
8
Convalescent plasma may be a possible treatment for COVID-19: A systematic review.恢复期血浆可能是治疗 COVID-19 的一种方法:系统评价。
Int Immunopharmacol. 2021 Feb;91:107262. doi: 10.1016/j.intimp.2020.107262. Epub 2020 Dec 5.
9
On the verge of the market - Plant factories for the automated and standardized production of biopharmaceuticals.在市场的边缘——用于生物制药自动化和标准化生产的植物工厂。
Biotechnol Adv. 2021 Jan-Feb;46:107681. doi: 10.1016/j.biotechadv.2020.107681. Epub 2020 Dec 14.
10
Production of recombinant butyrylcholinesterase from transgenic rice cell suspension cultures in a pilot-scale bioreactor.在中试规模生物反应器中利用转基因水稻细胞悬浮培养物生产重组丁酰胆碱酯酶。
Biotechnol Bioeng. 2021 Apr;118(4):1431-1443. doi: 10.1002/bit.27638. Epub 2020 Dec 13.